Characteristics of antigens from an HCG alpha secreting cell line (ElCo) derived from human breast carcinoma in a Native American patient.
OBJECTIVE
Our purpose is to report a cell line derived from a Native American patients that could serve as a model for ethnic diversity in cell culture research.


METHODS
Tumor biopsy specimens from reproductive tract malignancies were explanted in the cell culture laboratory. Characterization of a successfully established line included a parameter commonly observed in minority populations in rapid moving Type A glucose-6-phosphate dehydrogenase enzyme (G6-PD). Multiple other standard characterization studies were carried out.


RESULTS
A breast cancer cell line with a G6-PD-A enzyme was derived from an American Indian patient; this pattern is commonly observed in African-American populations. Results of lymphocyte-mediated cytotoxicity tests indicated that lymphocytes from patients with breast cancer were cytotoxic to ElCo cells. On the other hand, lymphocytes from patients with other types of cancer were not significantly different from healthy donor lymphocytes in their cytotoxicity. These studies indicate that ElCo cells express tumor-associated antigen(s). Many antigens of tumor cell origin were detected with use of antisera raised in rabbits in concentrates of ElCo cell culture fluid. One of these antigens was the alpha subunit of human chorionic gonadotropin.


CONCLUSIONS
Chemotherapy testing, vaccine production, and various new treatment schemes are most commonly developed in cell culture systems. These systems should reflect characteristics of the target population so that desired outcomes best fit the population being served. Thus the cell line being reported, which was derived from a Native American woman, represents a tool that can be used in cell culture research as a model for diversity.
Pattillo
R A
RA
Morehouse School of Medicine, Atlanta, GA 30310, USA.
Hussa
R O
RO
Story
M T
MT
D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis* / Q000276:immunology; D001940:Breast / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D001943:Breast Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D018270:Carcinoma, Ductal, Breast / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D002847:Chromatography, Agarose / Q000379:methods; D005260:Female; D005944:Glucosamine / Q000378:metabolism; D019298:Glucose-6-Phosphate / Q000032:analysis; D015292:Glycoprotein Hormones, alpha Subunit / Q000378:metabolism*; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D007198:Indians, North American; D008875:Middle Aged; D011233:Precipitin Tests; D011817:Rabbits; D011863:Radioimmunoassay; D013602:T-Lymphocytes, Cytotoxic / Q000473:pathology; D014316:Tritium; D014407:Tumor Cells, Cultured
D000951:Antigens, Neoplasm; D015292:Glycoprotein Hormones, alpha Subunit; D007106:Immune Sera; D014316:Tritium; D019298:Glucose-6-Phosphate; D005944:Glucosamine